Did you know that traditional Cardiopulmonary Exercise Testing (CPET) can cost hundreds of dollars per session and often requires bulky equipment and hospital visits? For many runners, this makes ...
Pharmacodynamic separation (PDS) of gemcitabine (Gem) and the epidermal growth factor receptor (EGFR) inhibitor erlotinib (E) in patients (Pts) with advanced pancreatic cancer: Phase II results. This ...
In a recent study posted to the medRxiv* pre-print server, researchers demonstrated reduced exercise capacity due to persistent cardiopulmonary symptoms among coronavirus disease 2019 (COVID-19) ...
"ATTR amyloidosis was characterized by distinct patterns of functional impairment across all disease phenotypes, attributable to multiple physiological mechanisms. Multiple CPET parameters were ...
For cardiopulmonary exercise testing (CPET), patients exercise on either a stationary bike or a treadmill. Cardiac, respiratory, and metabolic function are measured during warm-up and then during ...
Cardiopulmonary exercise testing (CPET), also known as ergospirometry, can be used for early detection of respiratory disorders in overweight and obese individuals. This is the main finding of a study ...
Researchers from the U.K. determined that preoperative cardiopulmonary exercise testing (CPET) is a specific predictor of 90-day survival following liver transplantation. Study results available in ...
Patients who have unexplained dyspnea months after recovering from COVID-19 often have objective signs of breathing problems on cardiopulmonary exercise testing (CPET) and meet criteria for myalgic ...
Against this background, we conducted a pilot study to evaluate the feasibility and safety of symptom-limited CPET and 6MWT in patients with high-risk or relapsed hematologic malignancies, after ...
To earn CME related to this news article, click here. February 26, 2009 — Cardiopulmonary exercise testing (CPET) helps predict mortality in idiopathic pulmonary fibrosis (IPF), according to the ...
Correspondence to Dr Meagan M Wasfy, Cardiovascular Performance Program, Massachusetts General Hospital, Boston, MA 02114, USA; mwasfy{at}partners.org Objectives Persistent or late-onset ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results